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During sex differentiation, androgens are essential for devel-
opment of the male genital tract. The Wolffian duct is an
androgen-sensitive target tissue that develops into the epi-
didymis, vas deferens, and seminal vesicle. The present study
aimed to identify androgen-regulated proteins that are in-
volved in development of Wolffian duct-derived structures.
We have used male mouse embryos transgenic for tempera-
ture-sensitive simian virus 40 large tumor antigen at 18 d of
gestation, to generate immortalized mouse fetal vas deferens
(MFVD) parental and clonal cell lines. The MFVD parental and
clonal cell lines express androgen receptor protein and show
features of Wolffian duct mesenchymal cells. Clonal cell line
MFVD A6 was selected for proteomic analysis and cultured in
the absence or presence of androgens. Subsequently, two-di-
mensional gel electrophoresis was performed on total cell ly-
sates. Differentially expressed proteins were analyzed by ma-
trix-assisted laser desorption/ionization time-of-flight mass
spectrometry and two androgen-regulated proteins were
identified as mElfin and CArG-binding factor-A (CBF-A).
CBF-A and mElfin are known to bind to cytoskeletal F-actin.
Both proteins appeared to be regulated by androgens at the
posttranslational level, possibly involving phosphorylation.
Posttranslational modification of mElfin and CBF-A by an-
drogens may be associated with a cytoskeletal change that is
involved in androgen-regulated gene expression. (Endocri-
nology 144: 1147–1154, 2003)
ANDROGENS ARE ESSENTIAL for development anddifferentiation of the male genital tract. Androgen
action is mediated by the androgen receptor (AR) that
functions as a transcription factor by binding to specific
DNA sequences in promoter and enhancer regions of tar-
get genes, thereby regulating their transcriptional activity
(1). During male embryonic development, testicular tes-
tosterone stimulates the Wolffian ducts to develop into
epididymides, vasa deferentia, and seminal vesicles. In the
urogenital sinus, 5-reductase converts testosterone into
the more potent 5-dihydrotestosterone, which stimulates
the urogenital sinus to develop into the prostate gland and
external genitalia (2). The importance of AR signaling
during male sexual differentiation is demonstrated in cer-
tain pathological situations, in particular androgen insen-
sitivity syndrome (reviewed in Ref. 3).
In the mouse Wolffian duct, AR expression can be de-
tected in mesenchymal cells from d 12.5 of gestation [em-
bryonic day (E) 12.5] onwards (4, 5) shortly before testic-
ular testosterone secretion starts (6). In contrast, epithelial
AR expression first appears in a temporal, cranial-to-
caudal fashion, starting in the efferent ductules at E16,
immediately after morphological differentiation of the
Wolffian duct has started. AR protein is not expressed in
epididymis and vas deferens epithelium before E19, and
in seminal vesicle epithelium before postnatal d 1 (4, 5).
The transition from AR negative to AR positive epithelium
between E18 and E19 in the mouse is similar to what is
found for fetal reproductive tract development in the rat
(7). Because androgen-dependent development of the gen-
ital tract occurs before epithelial cells express AR, it was
postulated that androgen action in epithelium is mediated
by paracrine influences from mesenchymal cells (8), sug-
gesting an important role for AR expressing mesenchymal
cells in the development of the genital tract. Thus, andro-
gen action in the developing Wolffian duct is mediated
solely by the AR-positive mesenchymal cells until E18, and
from E19 onwards by both the mesenchymal and the ep-
ithelial cells. Tissue recombination experiments have
proven to be successful model systems for investigating
mesenchymal-epithelial cell interactions in the reproduc-
tive tract and were used to identify growth factors as
androgen-induced paracrine factors (8, 9). However, it is
largely unknown which target genes, or other processes,
in the mesenchymal cells are regulated by androgens.
To study androgen regulation of protein expression in
mesenchymal cells, we developed androgen target cell
lines derived from E18 Wolffian duct mesenchymal tissue.
We used a transgenic mouse line that harbors the DNA
sequence encoding thermolabile simian virus (SV) 40 large
tumor (T) antigen under the direct control of an -actin
promoter. A clonal mouse fetal vas deferens (MFVD) cell
line was used for proteomic analysis. Comparative two-
dimensional gel electrophoresis (2DE) was performed, and
androgen-regulated proteins were identified using matrix-
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assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF-MS).
Materials and Methods
Materials
All media (Glutamax-supplemented DMEM/F12 nutrient mix and
Hanks’ balanced salt solution), HEPES, collagenase, trypsin, TRIzol re-
agent, multiwell tissue culture plates (NUNC, Roskilde, Denmark), and
filtertop culture flasks were purchased from Invitrogen Ltd. (Paisley, UK).
Fetal calf serum (FCS) was obtained from Greiner (Frickenhausen, Ger-
many). A mixture of penicillin, streptomycin, and fungizone was obtained
from BioWhittaker (Walkersville, MD). Deoxyribonuclease and complete
protease inhibitors were from Roche (Basel, Switzerland). NEN Life Science
Products (Boston, MA) supplied R1881 (methyltrienolone). Schering
(Bloomfield, NJ) provided hydroxyflutamide (OHF). Antibodies used were
SV 40 T Ag (Pab 101; Santa Cruz Biotechnology, Inc., Santa Cruz, CA),
antivimentin (clone VIM 3B4; Roche Molecular Biochemicals, Mannheim,
Germany), and anticalponin (clone hCP; Sigma, St. Louis, MO). PROTRAN
nitrocellulose transfer membranes were from Schleicher & Schuell (Keene,
NH). West-Pico chemiluminescence substrate was purchased from Pierce
Chemical Co. (Rockford, IL). Sequencing grade trypsin was from Promega
Corp. (Madison, WI). 10 Tris-glycine-sodium dodecyl sulfate (SDS) elec-
trophoresis buffer, TEMED (N,N,N,N-tetra-methyl-ethylenediamine), RC
DC Protein Assay and prestained precision protein standard were from
Bio-Rad Laboratories, Inc. (Hercules, CA). Immobiline dry immobilized pH
gradient (IPG) strips (pH 3–10 nonlinear, 18 and 24 cm), IPG buffer pH 3–10,
and PlusOne chemicals for isoelectric focusing (IEF) and 2DE and 12.5%
wt/vol acrylamide SDS precast gels were purchased from Amersham Bio-
sciences (Uppsala, Sweden). Duracryl (30% vol/vol acrylamide/0.8% vol/
vol BIS) was obtained from Genomic Solutions (Chelmsford, MA). Colloi-
dal Blue Staining Kit was from Novex/Invitrogen (Carlsbad, CA).-Cyano-
4-hydroxycinnamic acid and peptide calibration mix were from Bruker-
Daltonica (Bremen, Germany).
Animals
Young adult mice, age 10–12 wk (B10/CBA strain) were purchased
from Harlan Winkelmann GmbH (Bohren, Germany). Dr. E. Dzierzak
(Department of Cell Biology, Erasmus MC, Rotterdam, The Nether-
lands) kindly provided the SV 40 large T transgenic Tag 5 mice. Both
mice strains were housed under standard animal housing conditions in
accordance with the NIH Guide for the Care and Use of Laboratory
Animals. This study was approved by the Dutch experimental animal
committee, protocol no. 124-98-03.
Preparation of primary cell cultures
Timed pregnancies were performed by placing Tag 5 transgenic male
mice in individual cages overnight with B10/CBA females. Day 0 (E0) of
gestation was determined by the presence of a vaginal plug in the morning.
On d E18, females were killed, uteri were removed, and fetuses were
dissected in a sterile hood in DMEM/F12 medium containing 25 mm
HEPES, 5% vol/vol dextran-coated charcoal (DCC)-treated FCS, and a
mixture of penicillin/streptomycin/fungizone (PSF). Wolffian duct-de-
rived tissues were isolated and vasa deferentia from six animals were
pooled and washed twice in Ca2- and Mg2-free PBS. The tissues were
incubated in Hanks’ balanced salt solution with 150 U/ml collagenase and
1 g/ml deoxyribonuclease at 37 C for 30 min and were further dislodged
into a single-cell suspension by pipetting up and down. This cell suspension
was washed once with DMEM/F12 medium, supplemented with 5% (vol/
vol) DCC-FCS and PSF, and the cell number was determined. Cells were
subsequently seeded into 24-well plates at a density of 5 105 cells per well
and cultured at 33 C in DMEM/F12 supplemented with 5% DCC-FCS, PSF,
and 10 nm synthetic androgen R1881.
Establishment of vas deferens cell lines
After 1 wk of culture, medium from the cells was collected, centri-
fuged, and sterile filtered through a 0.22-m filter. This conditioned
medium was obtained freshly every week. Cells were washed with
Ca2-, Mg2-free PBS, detached with 0.25% (vol/vol) trypsin/0.05%
(wt/vol) EDTA by incubating at 33 C for 5 min and washed once with
medium. Subsequently, cells were seeded at a lower density of 5  104
cells/cm2 in medium as described above containing 20% (vol/vol) con-
ditioned medium, until cell crisis was reached. During cell crisis, cell
density was kept high, 2.5 105 cells/cm2, to promote cell proliferation.
Once the primary culture started proliferating again, it was considered
immortal. These cells were seeded at a density of 5  105 cells/80-cm2
culture flask. The immortalized cell line was designated parental MFVD.
To obtain clonal cell lines, limited dilution cloning was performed on the
MFVD cell line (passage 10) in a 48-well plate at an average density of
1 cell/well. After 1 wk of culture, colony formation had started. Medium
was replaced weekly, until the cell number in the well was high enough
to be passaged to larger plates. From this point on, addition of condi-
tioned medium was omitted and the R1881 concentration was lowered
to 1 nm. The immortalized cell cultures were passaged once a week.
Three clonal cell lines were obtained from the parental MFVD cell line,
designated clones A5, A6, and E2.
Growth studies
Growth studies were performed on the MFVD clone A6. At d 0, cells
were seeded, in duplicate, into 24-well plates at a density of 2 104 cells
per well. The cells were grown for 7 d in the presence of vehicle (0.1%
vol/vol ethanol), 1 nm R1881, or 100 nm antiandrogen OHF, at 33 and
39 C. On d 2, 5, and 7, cells were trypsinized and cell numbers were
determined using a hemocytometer.
Western blotting and immunoprecipitation
MFVD parental and clonal cell lines were grown in 80-cm2 culture
flasks for 7 d in the presence of vehicle or 1 nm R1881 at 33 and 37 C or
39 C. On d 4, medium and hormone were replaced. On d 7, the confluent
cell layer was washed twice with PBS, and cells were subsequently
collected by scraping on ice in 0.5 ml lysis buffer [40 mm Tris-HCl, 1 mm
EDTA (pH 7.4), 10% glycerol (vol/vol), 1% Triton X-100 (vol/vol), 0.08%
SDS (wt/vol), 0.5% sodium desoxycholate (wt/vol), 10 mm dithiothre-
itol, and complete protease inhibitors]. The obtained lysate was soni-
cated for 5 sec to decrease viscosity and centrifuged 10 min at 4 C, 50,000
rpm. Total protein lysate (25 g) was subjected to SDS-PAGE, and the
proteins were blotted onto a nitrocellulose membrane. The AR protein
was detected with monoclonal antibody F39.4.1 (10). Marker proteins
were detected using monoclonal antibodies against SV 40 T Ag, vimen-
tin, and calponin. In addition, AR protein was immunoprecipitated from
100 g total cell lysate with F39.4.1 and detected on blot with polyclonal
antiserum against synthetic peptide SP 213 (10). Proteins were visualized
by chemiluminescence detection, according to the instructions of the
manufacturer.
Northern blot analysis
MFVD parental and clonal cell lines were cultured in 80-cm2 culture
flasks for 7 d at 33 C. Total RNA was isolated using TRIZOL reagent
according to instructions of the manufacturer. Fifteen micrograms of
RNA of each sample were applied on a formamide gel and blotted
overnight to a PROTRAN nitrocellulose membrane. The Hoxa11 probe
was obtained using a 300-bp BamHI-BglII fragment of the mouse Hoxa11
cDNA (11) and was labeled with 32P-deoxy-ATP. Hybridization was
performed at 63 C overnight. RNA was visualized by autoradiography.
2DE
2DE was performed on protein lysates of MFVD A6 cells between
passages 12 and 18, which were cultured in 80-cm2 culture flasks as
described above in the presence of either vehicle (0.1% ethanol), 1 nm
R1881, or 10 nm testosterone for 24 h. After 7 d of culture, cells were
washed twice with PBS and collected in PBS. Cells from five 80-cm2
culture flasks from the same passage were pooled and centrifuged.
Pellets were solubilized with 2D lysis buffer containing 7 m urea, 2 m
thiourea, 4% wt/vol CHAPS (3-[3-(cholamidopropyl)-dimethyl-ammo-
nio]-1-propanesulfonate), 40 mm Tris-HCl, 10 mm dithiothreitol, and
complete protease inhibitors. This lysate was sonicated and centrifuged,
and protein concentration was determined as described above. For an-
alytical gels 100 g, and for preparative gels, 500 g protein lysate were
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mixed with rehydration buffer (8 m urea; 2% wt/vol CHAPS; 0.5%
vol/vol IPG buffer, pH 3–10; and a trace of bromophenol blue). Immo-
biline dry IPG gel strips of 18 cm for analytical (n  4) and 24 cm for
preparative gels (n 1) with a nonlinear pH range of 3–10 were actively
rehydrated overnight with sample containing rehydration buffer ap-
plying a voltage of 30 V/h (Vh). IEF was performed with an IPGphor
system (Amersham Biosciences) according to the manufacturer’s in-
structions, until 92 kVh was reached. After IEF, proteins in the gel strips
were reduced in equilibration buffer (6 m urea; 30% vol/vol glycerol; 2%
wt/vol SDS; 50 mm Tris-HCl, pH 8.8) with 60 mm dithiothreitol for
20 min, and subsequently carbamidomethylated in the same buffer,
containing 280 mm iodoacetamide, for 2 min. Resolution in the second
dimension was carried out in an Ettan-Dalt II system (Amersham Bio-
sciences) on 10% wt/vol Duracryl gels (analytical) or 12.5% wt/vol SDS
precast gels (preparative). The gels were run 20 min with a constant
power of 3 W and subsequently 3.5 h with a constant power of 180 W.
During the run the temperature was kept constant at 25 C. Prestained
protein standards were run together with the strips. The gels were fixed
overnight in 5% vol/vol phosphoric acid/40% vol/vol methanol, and
protein spots were visualized by colloidal Coomassie stain according to
the manufacturer’s instructions. Analytical gels were subsequently sil-
ver stained according to Morrissey (12).
In-gel trypsin digestion and mass spectrometry
Protein spots of interest were excised out of the gel, were washed
briefly in MilliQ water, destained twice for 20 min in 37% acetonitrile
(ACN)/2.5 mm ammonium hydrogen carbonate, washed again, vacuum-
dried for 30 min, digested overnight with sequencing grade trypsin (0.7
U per protein spot), and rehydrated in 50% vol/vol ACN/0.1% vol/vol
trifluoroacetic acid. The sample was mixed with a saturated -cyano-
4-hydroxycinnamic acid matrix solution in 100% ACN (one part sample
and four parts matrix), and 0.5 l of this mixture was spotted on an
anchorchip plate (Bruker-Daltonica). Digested peptide fragments were
analyzed in a MALDI-TOF-MS in a positive reflectron ion mode using
a Biflex III apparatus (Bruker-Daltonica). The obtained peptide mass
fingerprint spectra were analyzed searching the Matrix Science database
(MSDB) nonredundant protein database (National Center for Bio-
technology Information) with MASCOT software (http://www.
matrixscience.com), allowing one missed cleavage of trypsin per pep-
tide. After protein identification, the database was further searched
allowing the peptides to be modified for carbamidomethylation, oxi-
dation of methionine and phosphorylation. Peptide mass accuracy was
set to a maximum of 200 ppm. Upon protein identification, mass spectra
of different isoforms of one and the same protein were compared with
investigate the presence of modified peptides.
Results
Development of vas deferens cell lines and establishment of
their growth characteristics
An immortalized MFVD cell line was developed from vasa
deferentia from E18 mouse fetuses as described in Materials
and Methods. From this parental cell line, clonal cell lines
designated A5, A6, and E2 were derived. All cell lines were
continuously cultured at 33 C, the permissive temperature of
large T. Higher temperatures (37–39 C) cause degradation of
the large T protein and are therefore nonpermissive. It was
described for other immortalized cell lines that cell prolif-
eration at large T permissive conditions will stop, whereas
cell differentiation will be initiated (13, 14).
Initially, the MFVD parental and clonal cell lines were
continuously cultured under permissive conditions in the
presence of methyltrienolone (R1881), a synthetic andro-
gen. Growth studies were performed under variable cul-
ture. For this purpose, the MFVD clonal cell line A6 was
cultured for 7 d at 33 and 39 C in the absence of AR ligand,
in the presence of 1 nm R1881, or in the presence of 100 nm
of the OHF. Microscopic analysis revealed a difference in
morphology between cells cultured at 33 and 39 C (Fig. 1,
A and B). At 33 C, MFVD A6 cells were found to grow to
a high density, reaching confluency (Fig. 1A). At 39 C, the
cells developed a much larger and flatter appearance and
entered a more quiescent stage, although cell growth had
not completely stopped (Fig. 1B). Quantification of cell
growth showed a difference in growth between cells cul-
tured at 33 and 39 C (Fig. 1C). Culturing under large T
permissive conditions provided sufficient stimuli for cell
growth (Fig. 1C, open symbols). However, raising the cul-
ture temperature to 39 C resulted in a dramatic reduction
of cell proliferation (Fig. 1C, closed symbols). A reduction
in cell growth was observed to a lesser extent at 37 C (data
not shown). Cell growth at 33 and 39 C was neither stim-
ulated by R1881, nor inhibited by OHF. Western blot anal-
ysis showed a correlation between growth and large T
protein expression. As expected, large T protein was
highly expressed at 33 C in all cell lines (Fig. 1D, lanes 1,
3, 5, and 7). Shifting the temperature to 39 C (or 37 C; data
not shown) resulted in a decline of large T protein ex-
pression in the MFVD parental cell line, in MFVD clone A5,
and most prominent in MFVD clone A6 (Fig. 1D, lanes 2,
4, and 6). MFVD clone E2, however, did not show any large
T regulation, as the protein level remained high under
non-permissive conditions (Fig. 1D, lane 8). This may be
due to a varying basal level of large T protein between the
cell lines and to the turnover rate of the large T protein. It
can be concluded that differentiation of the MFVD A6
clone in particular is dependent on large T protein
expression.
MFVD cells are of Wolffian duct stromal origin
To select for the stromal cells in our vas deferens cultures,
the MFVD parental and clonal cells were cultured in serum-
containing medium. To confirm the stromal origin of MFVD
cells, some marker proteins were analyzed. On Western
blots, all clonal cell lines were positive for two mesenchymal
cell markers, vimentin, and calponin (Fig. 2A, lanes 1–3; Refs.
15 and 16). In contrast, the cells were negative for the epi-
thelial cell marker pan-keratin (a mixture of all cytokeratins;
Ref. 17). Chinese hamster ovary cells were used as a positive
control for mesenchymal cells (Fig. 2A, lane 4). The prostate
cancer cell line LNCaP was used as a control cell line for
epithelial cells expressing pan-keratin (Fig. 2A, lane 5).
To determine the vas deferens origin of these stromal cells,
Northern blot analysis was performed with a Hoxa11 probe.
This member of the Hoxa complex of homeotic genes is
expressed mainly in developing limbs and the embryonic
kidney (not in adult kidney), and in stromal cells surround-
ing the Mu¨llerian and Wolffian ducts (11). MFVD parental
and clonal cell lines expressed Hoxa11 mRNA (Fig. 2B, lanes
1–4), as did the embryonic kidney (positive control; Fig. 2B,
lane 5) but not the adult kidney (negative control; Fig. 2B,
lane 6). From these experiments, we conclude that the MFVD
parental and clonal cell lines have features of fetal vas de-
ferens mesenchyme.
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AR protein is expressed in MFVD parental and clonal
cell lines
Because cell growth in MFVD cell lines was not stimulated
by androgens, we investigated the expression level of the AR
protein. For that purpose, immunoprecipitation of AR pro-
tein from MFVD parental and clonal cell lines, cultured at 33
and 39 C, was performed (Fig. 3A). The parental cell line
showed AR protein expression at both large T permissive
and nonpermissive temperatures (Fig. 3A, lanes 1 and 2). All
three clonal cell lines showed AR expression. Whereas AR
expression at 33 C was rather low (Fig. 3A, lanes 3, 5, and 7),
it was clearly higher at 39 C (Fig. 3A, lanes 4, 6, and 8) when
cells were not under the control of large T and thus in a
differentiating state. In all our further studies, MFVD cells
were cultured at 37 C instead of 39 C, to provide a more
physiological temperature. AR expression was followed in
the MFVD A6 clone during a culture period of 20 passages,
by performing Western blots on whole cell lysates at pas-
sages 10 and 20. Figure 3B shows a relatively low AR ex-
pression at 33 and 37 C in the absence of R1881 (lanes 1, 3,
5, and 7). However, addition of R1881 to the cells resulted in
a marked increase in AR protein level (Fig. 3B, lanes 2, 4, 6,
and 8). This increase is most probably due to stabilization of
the receptor protein in the presence of ligand (18). In cells
cultured at 37 C, AR protein expression in the presence of
R1881 was more pronounced than at 33 C. The AR protein
expression was reduced at passage 20 (Fig. 3B, lanes 5–8)
compared with passage 10 (Fig. 3B, lanes 1–4). AR expression
was lost at passage 30 (results not shown). From these ex-
periments, it was concluded that the AR protein in the MFVD
A6 cell line is stabilized in the presence of ligand and that AR
protein expression is lost after 30 passages.
FIG. 1. Phase-contrast microscopy photographs of MFVD clonal cell line A6 at passage 20. The cells were cultured for 7 d at 33 C (A) and 39
C (B). Magnification, 200. Note the difference in morphology between cells cultured at 33 and 39 C. C, Growth curve of MFVD A6 clonal cell
line cultured at 33 C (closed symbols) and 39 C (open symbols) in the presence of vehicle (0.1% ethanol; squares), 1 nM R1881 (rectangles), or
100 nM OHF (triangles). Each point represents the SE of the mean (/ SEM) of three individual experiments performed in duplicate. The number
of cells grown for 7 d in the absence of hormone at 33 C was set at 100%, and all individual points were calculated relative to this value. D,
Western blot of large T protein expression in MFVD parental and clonal cell lines.
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CArG-binding factor-A (CBF-A) and mElfin are
differentially expressed in MFVD A6 cells
To identify proteins that are regulated by androgens, the
MFVD A6 cell line was used for proteomic analysis. MFVD
A6 protein lysates from four separate experiments were used
to generate analytical 2DE gels. Typically, silver-stained 2DE
gels showed approximately 1500 protein spots. Comparison
of protein expression patterns of control and androgen-
treated cells revealed only minor qualitative changes, except
for one part of the gels which showed, repeatedly (n  4), a
differential protein expression in a region focused between
pH 6 and 7 and between a molecular mass of 30–35 kDa. To
identify these differentially expressed proteins by MALDI-
TOF-MS, preparative 2DE gels were run. MFVD A6 cells
were either treated for 24 h with vehicle, 1 nm R1881, or 10 nm
testosterone. A colloidal Coomassie-stained gel from cells
treated with vehicle is shown in Fig. 4A. Approximately 400
protein spots could be visualized on these gels. Protein ex-
pression patterns of the cells cultured under different hor-
monal conditions were much alike, except for the region that
is boxed in Fig. 4A. A more detailed representation of this
part of the gel is shown in Fig. 4B, for all three culture
conditions. Protein spots a, b, c, and d represent nonchanging
anchors that were identified by MALDI-TOF-MS (Table 1).
Protein spots 1 and 2 present in the vehicle situation are
subject to changes upon androgen treatment. While spot 1 is
present in the vehicle situation, this protein disappears and
three other proteins appear at positions 1a, 1b, and 1c, upon
treatment with either R1881 or testosterone. The exposure to
R1881 or testosterone resulted in migration of protein spot 2
to position 2a and position 2b, respectively. Protein spots 1,
1a, 1b, and 1c could all be identified with MALDI-TOF-MS
as CBF-A (Table 1). Protein spots 2, 2a, and 2b were all found
to represent mElfin (Table 1). From the gels it is apparent that
addition of either 10 nm of the natural ligand testosterone or
1 nm of the synthetic androgen R1881 has the same effect on
the position of the protein spots representing CBF-A. How-
ever, 1 nm R1881 appears to have a different effect on the 2DE
migration of mElfin compared with the effect of 10 nm tes-
tosterone. No change in position of CBF-A and mElfin was
observed when cells were treated with 1 nm testosterone
(preliminary results, data not shown), which may be the
consequence of the lower affinity of testosterone for the AR
compared with dihydrotestosterone or R1881. Furthermore,
addition of 100 nm of an AR antogonist, hydroxyflutamide,
together with 1 nm R1881, blocks the effect of R1881 (pre-
liminary results, data not shown).
Proteins a–d in Fig. 4B and e–o encircled in Fig. 4A were
also identified to provide a further characterization of MFVD
A6 cells and are all listed in Table 1, together with their
molecular mass, theoretical and experimental isoelectric
point (pI), and accession number. In some cases, proteins did
not run in the gel according to their theoretical mass or pI,
and these proteins may have undergone modifications that
change their position in the gel. Using this proteomic ap-
proach, we have performed a small-scale analysis to further
characterize the MFVD A6 cell line. Several identified pro-
teins (protein disulfide isomerase precursor, laminin A, lami-
nin C, ATP-synthase -chain, and mitochondrial stress
protein-70) have been reported to be expressed in mouse
fibroblasts (19). The presence of these proteins in the MFVD
FIG. 3. AR protein expression. A, AR immunoprecipitation in MFVD
parental and clonal cell lines cultured at 33 and 39 C. B, AR protein
expression in A6 cell line at passages 10 and 20. A6 cells were cultured
at 33 or 37 C in the presence of vehicle (0.1% ethanol) or 1 nM R1881,
as indicated in the figure.FIG. 2. Characterization of MFVD parental and clonal cell lines. A,
Protein expression of two mesenchymal cell markers (vimentin and
calponin) and one epithelial cell marker (pan-keratin). Chinese ham-
ster ovary cells were used as mesenchymal control cells. LNCaP cells
were used as epithelial control cells. B, Hoxa11 mRNA expression in
MFVD clonal cell lines and mouse fetal kidney. Mouse adult kidney
was used as a negative control tissue.
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A6 cell line emphasizes the common mesenchymal charac-
teristics.
The presence of both CBF-A and mElfin under different
culture conditions but at changing positions in the gels
strongly suggests that these proteins undergo posttransla-
tional modification upon androgen treatment. Comparison
of the peptide mass fingerprint spectra of CBF-A isoforms 1,
1a, 1b, and 1c revealed some differential peptide peaks. In
isoform 1, 1a, and 1b, a peptide with a mass-to-charge ratio
(m/z) of 1939.71 was observed that was not present in iso-
form 1c. On the other hand, isoform 1c showed a peptide
with a m/z of 1539.79 that could not be observed in isoform
FIG. 4. Colloidal Coomassie-stained 2DE gel
of MDVD A6 cell lysate. A, Part of a 2DE gel
from cells cultured in the presence of vehicle
(0.1% ethanol) for 24 h. Proteins identified by
MALDI-TOF-MS are encircled and labeled
a–o. Boxed is a region with differential protein
expression. B, The boxed region from panel A
is shown in more detail. The same region is
shown in detail for 2DE gels from cells cul-
tured in the presence of 1 nM R1881 or 10 nM
testosterone. Differentially expressed pro-
teins are numbered as 1 and 2, for cell incu-
bations without ligand (vehicle). In the gels
representing the cells incubated with either
R1881 or testosterone, the differentially ex-
pressed proteins are numbered as 1a, 1b, 1c,
and 2a or 2b, respectively.
TABLE 1. Peptide mass fingerprinting by MALDI-TOF-MS
Spota Proteinb MM (kDa) tpI epI Accession no.
a Chaperonin containing TCP-1-chainc 57 6.0 6.3 BAA81874
b Ornithine amino transferase precursor 47 6.1 6.1 AAH08118
c, d -Enolase 47 6.4 6.4–6.6 P17182
e -Actin 41 5.3 5.1–5.4 P02570
f Vimentin 54 5.1 5.2–5.5 P20152
g ATP synthase -chain 56 5.0 5.1 P56480
h Protein disulfide isomerase precursor 57 4.8 4.8 P09103
i Mitochondrial stress-70 protein precursor 73 5.5 5.5 P38647
j Tropomyosin fibroblast isoform 1 33 4.6 4.6 P46901
k Laminin A 74 6.5 6.7–6.8 P48678
l Laminin C 64 6.4 6.7–6.8 P11516
m Mitochondrial matrix precursor protein P1 60 5.4 5.4 P19226
n -Aminobutyric acid A receptor, -6 32.9 5.7 5.7 AJ222970
o Proliferating cell nuclear antigen 28.8 4.7 4.7 P17918
1, 1a, 1b, 1c CArG-binding factor-Ad 30.8 7.7 6.4–6.8 JQ0448
2, 2a, 2b mElfin 35.7 6.4 6.4–6.6 AAH04809
a Index according to Fig. 4.
b Proteins identified with a significance of P  0.05 (MASCOT software, Matrix Science).
c TCP, t-complex polypeptide.
d CArG box  10 bp CC (A  T rich)6 GG sequence.
MM, Molecular mass; tpI, theoretical pI as calculated from the SWISS-PROT ExPASy database; epI, experimental pI measured from the
gels. Accession no. according to National Center for Biotechnology Information Blast.
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1, 1a, or 1b. According to the MSDB database search, which
is based on the peptide masses only and not on the precise
sequence, both these peptide masses match with CBF-A
amino acid residues 259–274, assuming that the 1939.71 pep-
tide has an extra mass that corresponds with 5 phosphate
residues (Table 2). Similarly, a putative phosphopeptide was
found with a m/z of 1189.58, corresponding to amino acid
residues 90–97 with two phosphorylated residues. For
mElfin, a putative phosphopeptide with m/z 1159.75 was
found only in isoform 2. Other predicted phosphopeptides
that were found in mElfin are listed in Table 2, together with
the putative phosphorylation sites.
Discussion
The present study addresses the development and char-
acterization of conditionally immortalized clonal cell lines
from mouse fetal vas deferens. Immortalized cell lines from
mouse urogenital ridge (20) and prepubertal mouse vas de-
ferens epithelium (21, 22) have been reported previously.
Other studies were performed using primary epithelial cells
from adult (23) and primary mesenchymal cells from fetal
reproductive tract (24). However, so far no clonal cell line
was described originating from fetal vas deferens mesen-
chymal cells. The MFVD A6 cell line is homogeneous because
of its clonal background, it is of stromal origin, and expresses
a functional androgen receptor. Therefore, these cells pro-
vide a cellular background that is suitable to study androgen
regulation of gene and protein expression in relation to fetal
genital tract development.
In addition to cDNA microarrays, proteomics is becoming
a widely used approach to study cellular mechanisms. The
study of proteins and posttranslational modifications adds to
what can be learned from genomic studies. Androgenic ef-
fects on gene and protein expression have been studied for
prostate cancer (25–27). However, the work presented herein
is the first proteomics study on the effects of androgens in
relation to genital tract development. In the MFVD A6 cell
line, we have identified CBF-A and mElfin as two proteins
that are regulated by androgens at the posttranslational level.
It is evident that a genomics approach would not have pro-
vided information about such a functional change in protein
expression.
In the differential 2DE analysis of androgen-treated MFVD
A6 cells vs. untreated cells, we primarily focused on quali-
tative differences. It was found that both CBF-A and mElfin
were present in the stimulated and nonstimulated cells but
as different protein isoforms. Comparing the peptide mass
fingerprint spectra of the different protein isoforms resulted
in identification of peptide masses that were present in either
one or the other protein isoform. Peptide phosphorylation
could account for these differences in mass, and possible
phosphopeptides were identified using the MSDB database.
In the case of the m/z 1939.71 peptide, the predicted presence
of 5 phosphorylated amino acid residues is remarkable. It
can, however, not be excluded that some other kind of mod-
ification, e.g. glycosylation, could result in a peptide of the
same mass as the putative phosphopeptide.
The MALDI-TOF-MS analysis of 2DE gels shows that post-
translational modification of CBF-A and mElfin occurs upon
androgen treatment and that peptide mass fingerprints can
provide clues as to what kind of modification is taking place.
Thus far, no androgenic regulation of CBF-A and mElfin at
the posttranslational level has been described.
CBF-A belongs to a subfamily of highly homologous A/B-
type heterogeneous nuclear ribonucleoproteins and functions
in both transcriptional and posttranscriptional processes of
gene regulation (28). CBF-A was originally described as a ubiq-
uitously expressed protein, which binds to CArG-box motifs
and to single-stranded DNA, and functions as a transcriptional
repressor (29). In a different context, the protein was found to
interact with the SP6promoter as a coactivator of transcription
(30). In addition, CBF-A activates transcription of the Ha-ras
promoter in mammary cells and appears to bind the Ha-ras
element 1 with higher affinity than the CArG box (31).
Furthermore, it was postulated that CBF-A is subject to post-
translational modification (30), and in a recent study it was
found that multiple modified isoforms of CBF-A associate with
actin and are involved in nuclear-cytoplasmic shuttling of
mRNA (32). In MFVD A6 cells, posttranslational modification
of CBF-A might influence the expression of specific androgen
target genes.
mElfin is a family member of the enigma proteins that
possess a PDZ domain at the amino terminal and a LIM
domain at the carboxyl terminal, which is expressed in a
variety of tissues (33). Expression of mElfin is found as early
as E8 in the developing heart of mouse embryos (34). LIM
domains are defined by cysteine-rich sequences (CX2
CX17–19HX2CX2CX2CX16–20CX2C/D/H) that form two zinc
fingers, and are involved in protein-protein interactions (re-
viewed in Ref. 35). LIM domains are found in a variety of
proteins with different cellular functions, especially in many
key regulators of developmental pathways (35). mElfin was
found to associate to the F-actin-rich cytoskeleton by inter-
acting with-actinin via its PDZ domain, which in turn binds
to F-actin (33, 36, 37). It was suggested that mElfin functions
as an adapter protein by recruiting signaling kinases to the
cytoskeleton via its protein-protein interaction motifs (34,
36). A functional relationship between mElfin and the AR
pathway can be similar to what has been observed for FHL2,
a four-and-a-half LIM domain protein that was found to be
TABLE 2. Proposed phosphopeptides according to differential MALDI-TOF-MS
Protein Modifiedpeptide m/z
Unmodified
peptide m/z Sequence Residues Candidate phosphorylation sites
CBF-A 1939.71 1539.70 GSGGGQGSTNYGKSQR 259–274 S260, S266, T267, Y269, S272
1189.58 1029.52 DLKDYFTK 90–97 Y94, T96
mElfin 1159.75 1079.73 CGTGIVGVFVK 261–271 T263
1805.94 1565.74 IKGCADNMTLTVSR 70–83 T78, T80, S82
2116.89 1796.82 GDADNMTLTVSRSEQK 72–87 T87, T80, S82, S84
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expressed preferentially in the heart (38). FHL2 is also ex-
pressed in epithelial cells of the prostate, where it overlaps
with nuclear AR expression and functions as an AR-specific,
ligand-dependent coactivator of transcription (39).
Another functional link to AR signaling may involve the
binding of CBF-A and mElfin to F-actin. It was described that
several proteins initially characterized as actin-binding proteins
or complexes were found to coactivate transcriptional regula-
tors, including AR. The F-actin binding protein filamin has been
found to interact with the AR and is involved in nuclear trans-
location of the AR (40). Likewise, -catenin, which plays a
pivotal role in cell-cell adhesion by linking cadherins to -
catenin and the actin cytoskeleton, and which is a downstream
effector of the Wnt signaling pathway, was found to enhance
androgen dependent transcriptional activity of the AR (41). It
is tempting to postulate that posttranslational modification of
mElfin and CBF-A in the presence of androgens may link a
change in cytoskeletal architecture to androgen-regulated gene
transcription.
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